Actually they license and sell part of company to fund trials so they don't dilute shareholders endlessly. It's just smart. Any early bio who is able to sell Off part of company as opposed To using toxic financing like redwood or dilution ends up benefiting shareholders the most.?
Market Data 
Markets 
AI
